A detailed history of Marshall Wace, LLP transactions in M Dx Health Sa stock. As of the latest transaction made, Marshall Wace, LLP holds 38,589 shares of MDXH stock, worth $139,306. This represents 0.0% of its overall portfolio holdings.

Number of Shares
38,589
Holding current value
$139,306
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

BUY
$2.12 - $4.68 $81,808 - $180,596
38,589 New
38,589 $178,000

Others Institutions Holding MDXH

# of Institutions
2
Shares Held
48.1K
Call Options Held
0
Put Options Held
0

About MDxHealth SA


  • Ticker MDXH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 16,288,100
  • Market Cap $58.8M
  • Description
  • MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, the Netherlands, Belgium, Spain, Poland, Italy, rest of European Union, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which prov...
More about MDXH
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.